Diabetes Program

The Harvard Stem Cell Institute (HSCI), three of Harvard’s clinical affiliates, and a biopharmaceutical company have formed an unusual collaboration to establish the Boston Autologous Islet Replacement Program (BAIRT) to accelerate a cure for diabetes...

Cambridge, MA, June 16,2016 - The Harvard Stem Cell Institute, three of Harvard’s clinical affiliates, and a biopharmaceutical company have formed a unique collaboration to establish the Boston Autologous Islet Replacement Program (BAIRT) to accelerate a...

Stem cell-derived, glucose-stimulated, insulin-producing cells (SC-β) are protected inside capsules engineered to be invisible to the host immune system. Photo courtesy of Omid Veiseh and Andrew Bader/Anderson/Langer Laboratory, Koch Institute at MIT...

Call for 2015 Nominations: Sternlicht Director's Fund Fellowship Nomination Deadline: September 25th, 2015 With generous support from Barry Sternlicht, the Harvard Stem Cell Institute (HSCI) announces the continuation of the Sternlicht Director's Fund...

Mesenchymal stem cells (green) colonize a pancreatic islet in a preclinical model of diabetes. The blue dots represent the nuclei of cells within the islet. by Haley Bridger, Brigham and Women's Hospital Communications Researchers at Harvard-affiliated...

Harvard researchers have created a system using human stem cells to screen for compounds that have the potential to turn white, or “bad,” fat cells into brown, or “good,” fat cells. Pictured are human pluripotent stem cell-derived fat cells. (Photo Credit...

Joe Zhou, an associate professor in Harvard’s Department of Stem Cell and Regenerative Biology (Photo Credit: B. D. Colen) By B. D. Colen, Harvard Staff Writer Harvard Stem Cell Institute (HSCI) researchers at five different Harvard departments and...